| Name | Title | Contact Details |
|---|
Winchester Business Systems is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
PaloDEx Group Oy operates in the international healthcare market, focusing on X-ray technology applications used in dental imaging. By offering high-quality imaging solutions that help in making the correct treatment decisions and in improving the level
Helen Keller Hospital is a not-for-proft, community hospital in Sheffield, AL. An acute care facility, Helen Keller Hospital is licensed to operate 185 beds. History Colbert County and the City of Sheffield opened a Hospital, March 22, 1921. At the time, this was called Colbert County Hospital. It is now known as Helen Keller Memorial Hospital, part of the Colbert County Healthcare Authority. Other healthcare entities under the umbrella the Colbert County Healthcare Authority include Red Bay Hospital, North Alabama Sleep Disorders Center and Northwest Practice Management. On May 21, 1979, the name of the hospital was changed to Helen Keller Hospital in honor of that great lady and world-renowned humanitarian. The continued growth of the Northwest Alabama Healthcare Authority is a result of the dedication of the Board of Trustees, the citizens of Colbert County and the hospital employees, who deliver excellent patient care. Helen Keller Hospital is fully accredited by the Joint Commission on Accreditation of Hospitals assuring the finest in medical care by the process of review inspection and updating. The Authority is governed by a nine-member Board of Trustees from Colbert County appointed by the County Commission serving in staggered six-year terms. While the Board of Trustees is ultimately responsible for the operation of the Authority, the details are delegated to the Authority President.
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
NxStage is more than just a company; we are leading the renal revolution. By our own design, we`re at the leading edge of a movement to transform renal care. To make it simpler. To make it portable. To expand treatment options for clinicians by overcoming traditional barriers. To enhance patient freedom and fulfillment. With significant breakthroughs already behind us - and others in the pipeline - NxStage is finding itself at the forefront of dramatically improved renal care, thanks to innovative yet simple therapeutic solutions that benefit patients, caregivers, and society. Our approach – and success is inspiring patients and providers.